Over one-quarter of US adults over 71 years have visual impairment

Article

The main outcomes were the national prevalence of impaired presenting distance VA, presenting near VA, and contrast sensitivity.

In excess of 25% of adults in the US who are 71 years and older have visual impairment. The differences in visual function were based on socioeconomic and demographic factors,1 according to first author Olivia Killeen, MD, MS, from the Department of Ophthalmology and Visual Sciences, and the Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

She and her colleagues conducted a survey-based study to determine the current updated national prevalence estimates of vision impairment and blindness among older US adults based on objective visual function testing.

The study was a secondary data analysis of the 2021 National Health and Aging Trends Study (NHATS), a population-based, nationally representative panel study of Medicare beneficiaries 65 years and older, the authors explains.

The participants were community-dwelling older adults or proxies who completed in-person interviews; annual follow-up interviews are conducted regardless of residential status. Round 11 NHATS data were collected from June to November 2021, and data were analyzed in August 2022.

The interventions were tablet-based tests of the distance and near visual acuity (VA) and contrast sensitivity with the participants’ habitual correction.

The study included 3,817 respondents. Ultimately, 3,026 respondents were included who had both completed the sample person interview and had no data missing; 29.5% of these respondents were aged 71 to 74 years old and 55% were women.

The main outcomes were the national prevalence of impaired presenting distance VA (>0.30 logMAR, Snellen equivalent worse than 20/40), presenting near VA (>0.30 logMAR, Snellen equivalent worse than 20/40), and contrast sensitivity (>1 standard deviation below the sample mean).

Visual impairment findings

“The prevalence of visual impairment in US adults 71 years and older was 27.8% (95% confidence interval [CI], 25.5%-30.1%). Distance and near VA and contrast sensitivity impairments were prevalent in 10.3% (95% CI, 8.9%-11.7%), 22.3% (95% CI, 20.3%-24.3%), and 10.0% (95% CI, 8.5%-11.4%), respectively,” the investigators reported.

Factors that were associated with all type of visual impairment included older age, lower education level, and lower income were associated with all types of visual impairment. Higher prevalence rates of near VA and contrast sensitivity impairments were associated with non-White race and Hispanic ethnicity.

The study concluded, “More than 1 in 4 US adults aged 71 years and older were visually impaired in 2021, which was higher than prior estimates. Differences in the prevalence of visual impairment by socioeconomic and demographic factors were observed. These data could inform public health planning.”

Reference
1. Killeen OJ, De Lott LB, Zhou Y, et al. Population prevalence of vision impairment in US adults 71 years and older. The National Health and Aging Trends Study.JAMA Ophthalmol. Published online January 12, 2023. doi:10.1001/jamaophthalmol.2022.5840
Recent Videos
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Dr. Ben Casella highlights the importance of SECO to the optometric community.
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Dr Ben Gaddie chats about his dry eye presentation at SECO and ocular surface disease.jpg
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Dr. Julie Rodman previews her SECO presentations
© 2025 MJH Life Sciences

All rights reserved.